News

Vietnam Investment Review on MSN9h
What lies ahead through US drug pricing shake-up
While Vietnam’s pharmaceutical manufacturers may face limited immediate exposure to the recent shifts in US drug pricing ...
ClearBridge Investments, an investment management company, released its “ClearBridge Large Cap Growth Strategy” second ...
While platform players are going super-wide in their offering, some legal AI startups are going the other way and drilling ...
SmartEsq’s new gen AI offering aims to automate the side letter compiling process and organize provisions to help users ...
The mini-agreement between India and US is 'awaiting final nods' and may focus on securing exemptions from the 26% percent ...
Royalty Pharma is less exposed to MFN drug pricing risks, offering downside protection in a volatile policy environment. See ...
With uncertainties clouding the outcome, Gokaldas Exports MD Sivaramakrishnan Ganapathi sees status quo as the base case, ...
Barbados and other CARICOM paint producers are set to receive regional tariff protection against external competitors, following a coordinated move led by ...
India wants the U.S. to remove all tariffs—both MFN and country-specific—on high and medium-labour-intensive goods. These ...
Heyman and Rollins have been hinting at a potential backup plan. The last time they mentioned a surprise, Bronson Reed joined ...